Gastric Cancer Therapy Market Industry, Trend Analysis and Forecast 2016 - 2030

It is estimated for the global gastric cancer therapy market to witness growth at a CAGR of 13.1% during the forecast period of 2022 to 2030.

The market has been witnessing growth from the previous forecast period of 2018 to 2021. Growth in the unhealthy habits of the population coupled with the rise in disease and the node from the pipeline candidates are the factors that are estimated to propel the growth of the market during the forecast period.

The Gastric Cancer can develop malignant (cancer) cells, making stomach cancer the fourth most prevalent type of cancer worldwide. Although the specific cause of stomach cancer is unknown, the bacterium Helicobacter pylori is one of the leading contributors.

An increase in unhealthy habits such as smoking and alcohol consumption, an increase in obesity, and a rising prevalence of gastroesophageal reflux disease all act as risk factors for gastric cancer. The increasing percentage of these diseases is estimated to boost the growth of the market during the forecast period.

The drugs including Herceptin and Cyramza are been repeatedly used for treating gastric cancer developed across the world. Apart from this, the adaption of PD-1 inhibitors such as Opdivo and Keytruda is estimated to bring change in the management of advanced metastatic stages of the disease.

To locate and diagnose stomach cancer, tests that look at the stomach and oesophagus are employed. The prognosis (chances of recovery) and available treatments are influenced by a number of factors. The fifth most common cancer in the world, stomach cancer claims about 700,000 lives each year.

Due to product launches, recent advancements in the stream of targeted therapy, and a tough clinical pipeline the segment of chemotherapy is estimated to hold the largest share of the gastric cancer drugs market by the end of the forecast period.

Covid-19 Impact on Gastric Cancer Therapy Market

Global healthcare systems have been impacted by the COVID-19 pandemic, which has also had a big effect on the market for therapies for stomach cancer. For instance, according to an article titled "Impact of COVID-19 on gastric cancer therapy in Japanese high-volume centres: a JCOG stomach cancer research group survey" that was published by the Nature Public Health Emergency Collection in July 2021, Hospitals in Tokyo suffered considerably from a 50% decline in this figure, which was recorded to be about 80% lower in 2020 than it was during the same period the year before. Therefore, it is anticipated that the decline in gastric cancer treatments during the pandemic will significantly affect the market under study. Additionally, according to an article in Cancer Connect 2020, researchers from the Dana Farber Cancer Institute found that diagnoses of the six most frequent cancer types, including stomach cancer, decreased by 46% during the COVID-19 pandemic. However, with the lifting of COVID-19 restrictions, treatment and services are once again being provided, which is anticipated to result in an increase in hospital visits.

Key Market Trends

Owing to the high prevalence of the disease and the availability of various products, it is estimated for the gastroesophageal junction cancer segment to drive the growth of the market during the forecast period. Owing to the increasing number of product launches it is estimated for the gastrointestinal stromal tumours segment to witness a healthy growth in the market.

Further, owing to the launch and integration of PD-1 inhibitors including Opdivo and Keytruda in gastric cancer therapy treatment it is anticipated for immunotherapy to boost the growth of the market during the forecast period based on the segment of the type of treatment.

Asia Pacific region is expected to maintain its dominance during the forecast period and at the same time, Europe is anticipated to see a rise in the market during the forecast period owing to the increasing target patient population.

Get Free Sample Report:  https://wemarketresearch.com/sample-request/gastric-cancer-therapy-market/416/

Segmental Analysis of the Market

By Treatment Type

Chemotherapy

Immunotherapy

Targeted Therapy

Radiation Therapy And Surgery

It is estimated for the chemotherapy category to boost the growth of the market.

By Indication Outlook

Gastric Cancer/Gastroesophageal Junction Cancer

Gastrointestinal Stromal Tumors

It is estimated for stromal cancers to lead the market during the forecast period.

By Route of Treatment

Oral

Injectable

It is estimated for the oral category to boost the growth of the market.

Asia Pacific region to witness growth at a the fastest pace

Asia Pacific region is expected to maintain its dominance during the forecast period and at the same time Europe is anticipated to see a rise in the market during the forecast period owing to the increasing target patient population. The high disease burden and research initiatives in Asia Pacific region is estimated to boost the growth of the market.

Competitive Landscape

Some of the prominent companies operating in the market are

Novartis AG

Pfizer, Inc.

Mylan N.V.

1. Hoffmann La Roche Ltd.

Eli Lilly And Company

Merck & Co., Inc.

Teva Pharmaceutical Industries Ltd.

Celltrion Healthcare Co., Ltd.

Samsung Bioepis

Bristol Myers Squibb Company

Get More Information About This Report:

https://wemarketresearch.com/reports/gastric-cancer-therapy-market/416/

Frequently Asked Questions:

• What is the growth rate projection for Global Gastric Cancer Therapy Market over 2022-2030?
• What are the expansion determinants of Global Gastric Cancer Therapy Market?
• What are the major segments covered in the Global Gastric Cancer Therapy Market?
• What are the prime regions present in the Global Gastric Cancer Therapy Market?
• Which is the fastest growing region in the Global Gastric Cancer Therapy Market?

About We Market Research:

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

Contact Us:

We Market Research

Phone: +1(650)-666-4592

Email: sales@wemarketresearch.com

Web: https://wemarketresearch.com/